Evofem Biosciences Inc reports results for the quarter ended in December - Earnings Summary

Evofem Biosciences

03/03/2022 22:01

* Evofem Biosciences Inc  EVFM.OQ  reported a quarterly
adjusted
loss of 33 cents​​ per share for the quarter ended in December.
The mean expectation of four analysts for the quarter was for a
loss of 23 cents per share.
    * Revenue rose 2,025% to $3.57 million from a year ago; 
analysts
expected $3.36 million. 
    * Evofem Biosciences Inc's reported EPS for the quarter was
a loss
of 33 cents​.
    * The mean earnings estimate of analysts had risen by
about 10.8%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Evofem Biosciences Inc shares had risen by 42.0% this
quarter.
    * The company reported a quarterly loss of $52.6 million.
    * Wall Street's median 12-month price target for Evofem
Biosciences Inc is $2.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated March 3 at 10:00 p.m.  ​All
figures in US dollars unless otherwise stated